GENZYME - THE KING OF THE BIOTECHS Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GENZYME - THE KING OF THE BIOTECHS

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Vector1 who wrote (281)	7/13/1998 8:16:00 PM
From: Caveat Emptor	Read Replies (1) of 410

Further Information-Insider Shift and General Partnership It is important that we understand the breakdown of this partnership/Venture Funding unit of Genzyme. This recent shift of partnership units may have profited the General Partners. The General Partners are Executives of the Company. Genzyme Development PArtners, LP Organized October 16, 1989 - MA Agent: Peter Wirth, Esq. - As Secretary of GP Directors and Officers of GDP, LP * Henri Termeer - President and Director since 1989 * Peter N. Reikes - Director since 1996 Reikes is Managing Director of the Health Care Group within the Investment Banking Division of Paine Webber (since 1985) (Appointed to board by PW R+D Partners 11) * W. Gerald Austien, MD - Appointed to Board - 1990 Appointed by PW R+D Partners 11 David J. McLachlan - Director since 1990 Earl M. Collier, Jr - Director since 1997 Comments or questions? I would welcome a discussion on this issue. Thanx CAVEAT EMPTOR

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next